NYSE International 100

NYSE International 100 handeln
10.349,17 PKT -60,48 PKT -0,58 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Analysen zu NYSE International 100-Werten

Datum Rating Analyst
21:31 AstraZeneca Overweight JP Morgan Chase & Co.
18:36 UBS Kaufen DZ BANK
18:06 Unilever Sector Perform RBC Capital Markets
14:06 ING Group Sector Perform RBC Capital Markets
13:51 ABB (Asea Brown Boveri) Neutral Goldman Sachs Group Inc.
13:51 BBVA Neutral UBS AG
13:46 ING Group Buy UBS AG
13:46 BBVA Sector Perform RBC Capital Markets
13:46 Unilever Sector Perform RBC Capital Markets
13:36 GSK Hold Deutsche Bank AG
13:36 AstraZeneca Sell Deutsche Bank AG
13:31 UBS Buy Deutsche Bank AG
13:06 Santander Buy Deutsche Bank AG
12:26 GSK Underweight JP Morgan Chase & Co.
12:26 Unilever Overweight JP Morgan Chase & Co.
12:11 BBVA Overweight JP Morgan Chase & Co.
10:56 Mercedes-Benz Group (ex Daimler) Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
10:26 GSK Underweight Barclays Capital
10:26 Santander Overweight Barclays Capital
10:26 TotalEnergies Overweight Barclays Capital
10:16 Unilever Outperform Bernstein Research
09:36 UBS Equal Weight Barclays Capital
09:36 ING Group Overweight Barclays Capital
08:41 Mercedes-Benz Group (ex Daimler) Market-Perform Bernstein Research
08:01 GSK Neutral Goldman Sachs Group Inc.
29.04.26 UBS Overweight JP Morgan Chase & Co.
29.04.26 GSK Halten DZ BANK
29.04.26 TotalEnergies Kaufen DZ BANK
29.04.26 Deutsche Bank Kaufen DZ BANK
29.04.26 Philips Overweight Barclays Capital
29.04.26 AstraZeneca Kaufen DZ BANK
29.04.26 Mercedes-Benz Group (ex Daimler) Sector Perform RBC Capital Markets
29.04.26 Mercedes-Benz Group (ex Daimler) Neutral UBS AG
29.04.26 BP Buy Goldman Sachs Group Inc.
29.04.26 Novartis Neutral UBS AG
29.04.26 Unilever Hold Deutsche Bank AG
29.04.26 Santander Buy UBS AG
29.04.26 TotalEnergies Buy UBS AG
29.04.26 GSK Underweight JP Morgan Chase & Co.
29.04.26 AstraZeneca Overweight Barclays Capital